Baker Brothers Advisors - DICERNA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,250,000
+10.6%
102,121
-9.7%
0.01%0.0%
Q3 2020$2,035,000
-32.9%
113,135
-5.2%
0.01%
-38.5%
Q2 2020$3,031,000
+101.4%
119,335
+45.6%
0.01%
+44.4%
Q1 2020$1,505,00081,9350.01%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,813,392$67,676,00017.58%
Bain Capital Life Sciences Investors, LLC 3,080,237$114,954,0007.53%
RTW INVESTMENTS, LP 7,521,859$280,716,0004.24%
DAFNA Capital Management LLC 510,756$19,061,0003.99%
SILVERARC CAPITAL MANAGEMENT, LLC 229,892$8,580,0003.83%
Parkman Healthcare Partners LLC 304,686$11,371,0002.49%
Evolutionary Tree Capital Management, LLC 141,324$5,274,0002.43%
Eagle Health Investments LP 161,125$6,013,0002.06%
Lombard Odier Asset Management (Switzerland) SA 636,011$23,736,0001.20%
Woodline Partners LP 1,000,325$37,332,0000.70%
View complete list of DICERNA PHARMACEUTICALS INC shareholders